Announce Date | 04/23/2025 |
EPS Normalized Actual | $0.64 (Beat by $0.025) |
EPS GAAP Actual | $0.64 (Beat by $0.025) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.66213 |
EPS GAAP Estimate | $0.66213 |
Revenue Estimate | $2.033840944B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 6.91 | 13.61 | 6.62583 | 7.60608 | 1 |
Dec 2028 | 5.87 | 16.02 | 5.73587 | 6.11984 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.43 | -0.03181 | 0B | -INF% | -1784.37M |
FQ4 2024 (Dec 2024) | 0.39 | 0.39 | 0B | -INF% | 0M |
FQ3 2024 (Sep 2024) | 0 | 0 | 4.147B | 57.98% | 4147M |
FQ2 2024 (Jun 2024) | 0.48 | 0.48 | 1.9528B | -77.6% | 1952.8M |
FQ1 2024 (Mar 2024) | 0 | 0 | 3.2782B | 53.6% | 3278.2M |
FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 1.8654B | 11.3% | 1865.4M |
FQ3 2023 (Sep 2023) | 0.25 | 0.25 | 1.7426B | 15.01% | 1742.6M |
FQ2 2023 (Jun 2023) | 0 | 0 | 3.4682B | 59.65% | 3468.2M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.66213
Consensus Revenue Estimates
2.033840944B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.4234 | -- | 1.4234 | 1.4234 | 4 |
FQ3 2027 (Sep 2027) | 1.3049 | -- | 1.3049 | 1.3049 | 3 |
FQ2 2027 (Jun 2027) | 1.2624 | -- | 1.2624 | 1.2624 | 4 |
FQ1 2027 (Mar 2027) | 0.8639 | -- | 0.8639 | 0.8639 | 3 |
FQ4 2026 (Dec 2026) | 1.2139 | -- | 1.2139 | 1.2139 | 4 |
FQ3 2026 (Sep 2026) | 1.1055 | -- | 1.1055 | 1.1055 | 3 |
FQ2 2026 (Jun 2026) | 1.0659 | -- | 1.0659 | 1.0659 | 4 |
FQ1 2026 (Mar 2026) | 0.7382 | 41.75 | 0.7382 | 0.7382 | 3 |
FQ4 2025 (Oct 2025) | 0.81405 | 52.09 | 0.77962 | 0.84873 | 3 |
FQ3 2025 (Jul 2025) | 0.74611 | -- | 0.71456 | 0.7779 | 3 |
FQ2 2025 (Jun 2025) | 0.66213 | 27.51 | 0.64442 | 0.67733 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.04B | -- | 3.04B | 3.04B | 5 |
FQ3 2027 (Sep 2027) | 2.83B | -- | 2.83B | 2.83B | 4 |
FQ2 2027 (Jun 2027) | 2.77B | -- | 2.77B | 2.77B | 5 |
FQ1 2027 (Mar 2027) | 2.34B | -- | 2.34B | 2.34B | 4 |
FQ4 2026 (Dec 2026) | 2.78B | -- | 2.78B | 2.78B | 5 |
FQ3 2026 (Sep 2026) | 2.58B | -- | 2.58B | 2.58B | 4 |
FQ2 2026 (Jun 2026) | 2.53B | -- | 2.53B | 2.53B | 5 |
FQ1 2026 (Mar 2026) | 2.14B | -- | 2.14B | 2.14B | 4 |
FQ4 2025 (Oct 2025) | 2.16B | -- | 2.09B | 2.23B | 2 |
FQ3 2025 (Jul 2025) | 2.13B | -94.45 | 2.06B | 2.2B | 2 |
FQ2 2025 (Jun 2025) | 2.03B | 3.98 | 1.99B | 2.07B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
1
EPS # of in-lines
3
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.46181 | 0.43 | -0.03181 | -7.4% |
FQ4 2024 (Dec 2024) | 0.39 | 0.39 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0.48 | 0.48 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 100% | |
FQ3 2023 (Sep 2023) | 0.25 | 0.25 | 100% | |
FQ2 2023 (Jun 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.78B | $0B | $-1784.37M | -INF% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $4.15B | $4147M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.95B | $1952.8M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.28B | $3278.2M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.87B | $1865.4M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.74B | $1742.6M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.47B | $3468.2M | 100% |